DarioHealth Corp. (DRIO)
1.26
-0.39
(-23.64%)
USD |
NASDAQ |
Nov 13, 16:00
1.32
+0.06
(+4.76%)
After-Hours: 19:59
DarioHealth Enterprise Value : 15.13M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 15.13M |
| November 12, 2026 | 19.49M |
| November 11, 2026 | 24.81M |
| November 10, 2026 | 27.78M |
| November 09, 2026 | 24.08M |
| November 06, 2026 | 27.61M |
| November 05, 2026 | 31.53M |
| November 04, 2026 | 34.27M |
| November 03, 2026 | 34.61M |
| November 02, 2026 | 34.95M |
| October 30, 2026 | 34.61M |
| October 29, 2026 | 38.08M |
| October 28, 2026 | 39.20M |
| October 27, 2026 | 39.98M |
| October 26, 2026 | 39.09M |
| October 23, 2026 | 43.23M |
| October 22, 2026 | 39.20M |
| October 21, 2026 | 42.22M |
| October 20, 2026 | 46.70M |
| October 19, 2026 | 51.29M |
| October 16, 2026 | 54.99M |
| October 15, 2026 | 58.46M |
| October 14, 2026 | 62.04M |
| October 13, 2026 | 63.05M |
| October 12, 2026 | 61.71M |
| Date | Value |
|---|---|
| October 09, 2026 | 65.96M |
| October 08, 2026 | 61.82M |
| October 07, 2026 | 69.10M |
| October 06, 2026 | 68.42M |
| October 05, 2026 | 65.96M |
| October 02, 2026 | 73.35M |
| October 01, 2026 | 69.99M |
| September 30, 2026 | 75.14M |
| September 29, 2026 | 66.76M |
| September 28, 2026 | 67.42M |
| September 25, 2026 | 66.84M |
| September 24, 2026 | 67.86M |
| September 23, 2026 | 67.64M |
| September 22, 2026 | 68.74M |
| September 21, 2026 | 70.07M |
| September 18, 2026 | 71.02M |
| September 17, 2026 | 69.48M |
| September 16, 2026 | 67.94M |
| September 15, 2026 | 67.72M |
| September 14, 2026 | 70.21M |
| September 11, 2026 | 69.04M |
| September 10, 2026 | 66.47M |
| September 09, 2026 | 68.23M |
| September 08, 2026 | 69.77M |
| September 04, 2026 | 71.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teladoc Health, Inc. | 1.789B |
| Dogecoin Cash, Inc. | 2.411M |
| CompuMed, Inc. | 5.971M |
| Cannabis Strategic Ventures, Inc. | 2.128M |
| Evolent Health, Inc. | 1.372B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.849M |
| Revenue (Quarterly) | 5.311M |
| Total Expenses (Quarterly) | 14.16M |
| EPS Diluted (Quarterly) | -0.7337 |
| Gross Profit Margin (Quarterly) | 59.22% |
| Profit Margin (Quarterly) | -166.6% |
| Earnings Yield | -410.1% |
| Normalized Earnings Yield | -417.92 |